FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.
New Rx, indications, generics, and OTC
It's back-to-school season. Mom and Dad can be losing their hair for a few reasons — finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.
FDA has approved pembrolizumab (Keytruda, Merck) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Pembrolizumab, which received breakthrough therapy designation for advanced melanoma, is the sixth new melanoma treatment approved since 2011.
A University of Kentucky pharmacy professor has developed a quicker, easier way to deliver naloxone via a nasal spray, and his invention is being fast-tracked by the Food and Drug Administration, according to a report in the Lexington Herald-Leader.
Summer's not over yet. For customers planning August vacations or anyone with active children, here are some new options for the first-aid kit.
NOH is a rare, chronic, and debilitating drop in blood pressure upon standing. It is associated with Parkinson's disease, multiple system atrophy, and pure autonomic failure.
New Rx, generics, and OTC
FDA has approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease (COPD). The long-acting beta-adrenergic agonist (LABA) by Boehringer Ingelheim Pharmaceuticals can be used once daily as maintenance therapy.
A besetting problem in a screen-obsessed age, dry eye can be distractingly painful. Several companies offers products that promise relief.